HK1062402A1 - Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops - Google Patents
Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotropsInfo
- Publication number
- HK1062402A1 HK1062402A1 HK04104813.3A HK04104813A HK1062402A1 HK 1062402 A1 HK1062402 A1 HK 1062402A1 HK 04104813 A HK04104813 A HK 04104813A HK 1062402 A1 HK1062402 A1 HK 1062402A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- psychotrops
- desoxypeganine
- intoxications
- nervous system
- central nervous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10119863A DE10119863A1 (de) | 2001-04-24 | 2001-04-24 | Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen |
PCT/EP2002/004278 WO2002087553A2 (de) | 2001-04-24 | 2002-04-18 | Verwendung von desoxypeganin zur behandlung von krankheitserscheinungen des zentralen nervensystems aufgrund von intoxikationen mit psychotropen substanzen |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1062402A1 true HK1062402A1 (en) | 2004-11-05 |
Family
ID=7682410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04104813.3A HK1062402A1 (en) | 2001-04-24 | 2004-07-05 | Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops |
Country Status (28)
Country | Link |
---|---|
US (1) | US20040132751A1 (no) |
EP (1) | EP1383503B1 (no) |
JP (1) | JP2004526791A (no) |
KR (1) | KR20030094365A (no) |
CN (1) | CN1638774A (no) |
AR (1) | AR033469A1 (no) |
AT (1) | ATE411024T1 (no) |
AU (1) | AU2002325209B2 (no) |
BR (1) | BR0209125A (no) |
CA (1) | CA2445132C (no) |
CZ (1) | CZ20032788A3 (no) |
DE (2) | DE10119863A1 (no) |
DK (1) | DK1383503T3 (no) |
EA (1) | EA200301134A1 (no) |
ES (1) | ES2316595T3 (no) |
HK (1) | HK1062402A1 (no) |
HU (1) | HUP0303921A3 (no) |
IL (1) | IL158383A0 (no) |
MX (1) | MXPA03009766A (no) |
MY (1) | MY135676A (no) |
NO (1) | NO20034741L (no) |
NZ (1) | NZ529005A (no) |
PL (1) | PL366845A1 (no) |
PT (1) | PT1383503E (no) |
SI (1) | SI1383503T1 (no) |
SK (1) | SK287214B6 (no) |
WO (1) | WO2002087553A2 (no) |
ZA (1) | ZA200308042B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10354893B4 (de) * | 2003-11-24 | 2011-03-10 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen |
DE10354894A1 (de) * | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Orale Formulierungen des Desoxypeganins und deren Anwendungen |
ES2360547B1 (es) * | 2009-11-02 | 2012-07-04 | Consejo Superior De Investigaciones Científicas (Csic) | Procedimiento de obtención de los alcaloides activos de la planta medicinal peganum harmala y su uso. |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
DE3843239C1 (no) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
US5602184A (en) * | 1993-03-03 | 1997-02-11 | The United States Of America As Represented By Department Of Health And Human Services | Monoterpenes, sesquiterpenes and diterpenes as cancer therapy |
DE19906974C2 (de) * | 1999-02-19 | 2003-10-09 | Lohmann Therapie Syst Lts | Verwendung von Desoxypeganin zur Behandlung des Alkoholismus |
DE19906975B4 (de) * | 1999-02-19 | 2004-04-15 | Lts Lohmann Therapie-Systeme Ag | Arzneiform zur Behandlung von Alzheimer'scher Demenz |
DE19906978B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit |
DE19906979B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
DE19906977C1 (de) * | 1999-02-19 | 2000-06-15 | Lohmann Therapie Syst Lts | Desoxypeganin-TTS und seine Verwendung |
DE19924951B4 (de) * | 1999-05-31 | 2004-02-05 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer |
CA2389865A1 (en) * | 1999-11-04 | 2001-05-10 | Xel Herbaceuticals | Transdermal administration of huperzine |
-
2001
- 2001-04-24 DE DE10119863A patent/DE10119863A1/de not_active Withdrawn
-
2002
- 2002-04-18 JP JP2002584899A patent/JP2004526791A/ja active Pending
- 2002-04-18 PL PL02366845A patent/PL366845A1/xx not_active IP Right Cessation
- 2002-04-18 HU HU0303921A patent/HUP0303921A3/hu unknown
- 2002-04-18 AT AT02758191T patent/ATE411024T1/de not_active IP Right Cessation
- 2002-04-18 SK SK1316-2003A patent/SK287214B6/sk not_active IP Right Cessation
- 2002-04-18 WO PCT/EP2002/004278 patent/WO2002087553A2/de active Application Filing
- 2002-04-18 PT PT02758191T patent/PT1383503E/pt unknown
- 2002-04-18 DK DK02758191T patent/DK1383503T3/da active
- 2002-04-18 US US10/475,788 patent/US20040132751A1/en not_active Abandoned
- 2002-04-18 SI SI200230779T patent/SI1383503T1/sl unknown
- 2002-04-18 EA EA200301134A patent/EA200301134A1/ru unknown
- 2002-04-18 CA CA002445132A patent/CA2445132C/en not_active Expired - Fee Related
- 2002-04-18 KR KR10-2003-7013972A patent/KR20030094365A/ko active Search and Examination
- 2002-04-18 MX MXPA03009766A patent/MXPA03009766A/es active IP Right Grant
- 2002-04-18 EP EP02758191A patent/EP1383503B1/de not_active Expired - Lifetime
- 2002-04-18 DE DE50212901T patent/DE50212901D1/de not_active Expired - Lifetime
- 2002-04-18 AU AU2002325209A patent/AU2002325209B2/en not_active Ceased
- 2002-04-18 CN CNA028088891A patent/CN1638774A/zh active Pending
- 2002-04-18 BR BR0209125-9A patent/BR0209125A/pt not_active IP Right Cessation
- 2002-04-18 IL IL15838302A patent/IL158383A0/xx not_active IP Right Cessation
- 2002-04-18 ES ES02758191T patent/ES2316595T3/es not_active Expired - Lifetime
- 2002-04-18 NZ NZ529005A patent/NZ529005A/en unknown
- 2002-04-18 CZ CZ20032788A patent/CZ20032788A3/cs unknown
- 2002-04-22 MY MYPI20021470A patent/MY135676A/en unknown
- 2002-04-24 AR ARP020101483A patent/AR033469A1/es unknown
-
2003
- 2003-10-16 ZA ZA200308042A patent/ZA200308042B/en unknown
- 2003-10-23 NO NO20034741A patent/NO20034741L/no unknown
-
2004
- 2004-07-05 HK HK04104813.3A patent/HK1062402A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1434801A4 (en) | TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM | |
IL176581A0 (en) | Immunomodulatory compounds for the treatment of central nervous system disorders | |
IL209842A0 (en) | Compounds for the treatment of metabolic disorders | |
IL178648A0 (en) | Substituted morpholine compounds for the treatment of central nervous system disorders | |
IL160884A0 (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
EP1274444A4 (en) | DRUGS FOR THE TREATMENT OF PSYCHIATRICAL OR ABUSUS-RELATED DISORDER | |
ZA200702523B (en) | Process for the purification of 1,4-butanediol | |
AU2003249983A8 (en) | Piperidines useful for the treatment of central nervous system disorders | |
IL162485A0 (en) | Compounds for the treatment of inflammatory disorders | |
EP1654260A4 (en) | 6-LOW HETEROARYL COMPOUNDS FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES | |
EG23150A (en) | Process for the purification of pharmacologically active proteins through cathionic enhance chromatography | |
EP1658072A4 (en) | Compounds for the Treatment of Neurodegenerative Diseases | |
HUP0302530A3 (en) | Process for the purification of 2-nitro-4-methylsulphonylbenzoic acid | |
EP1448193A4 (en) | THERAPEUTIC COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEAMIC CONDITIONS | |
EP1461030A4 (en) | AMINOALKYL-BENZOFURAN-5-OL COMPOUNDS FOR THE TREATMENT OF GLAUCOMA | |
IL162172A0 (en) | Methods for the purification of levofloxacin | |
IL162455A0 (en) | Compounds for the treatment of sexual dysfunction | |
EP1458694A4 (en) | THERAPEUTIC COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEAMIC CONDITIONS | |
HUP0303921A3 (en) | Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops | |
AU2002325209A1 (en) | Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops | |
GB0123145D0 (en) | Apparatus for the purification of water | |
IL154378A0 (en) | Compounds for the treatment of addictive disorders | |
SI1468686T1 (sl) | S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj | |
EP1389129A4 (en) | METHOD FOR TREATING RESPIRATORY DISEASES | |
AU2002339699A8 (en) | Use of obg3 for promoting central nervous system remyelination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20130418 |